“Renibus is a clinical stage biopharmaceutical company with novel programs to halt and manage progression of cardiorenal diseases. For our three sequential Phase 1B studies, we needed to be very efficient as we tested our therapies to ultimately improve patient outcomes. Application of CliniOps’ unified technologies was valuable for the seamless conduct of the studies and consequently helped to lessen the burden for both study team and participants.”